Literature DB >> 22201841

Antimycobacterials from natural sources: ancient times, antibiotic era and novel scaffolds.

Juan D Guzman1, Antima Gupta, Franz Bucar, Simon Gibbons, Sanjib Bhakta.   

Abstract

Mycobacteria are a group of aerobic, non-motile, acid fast bacteria that have a characteristic cell wall composed of a mycolyl-arabinogalactan-peptidoglycan complex. They display different phenotypic attributes in their growth, color and biochemistry. Tuberculosis (TB) is defined as the infection with Mycobacterium tuberculosis complex and was declared a global health emergency principally because of the appearance of multidrug-resistant strains and the associated risk of infection in immune-compromised population. There is an urgent clinical need for novel, potent and safe anti-TB drugs. Natural products have been used since antiquity for treating diverse complaints and novel pharmacophores are discovered every year. Two of the most potent used antimycobacterials, the rifamycins and streptomycin, were first detected in Streptomyces bacteria. Plants are also the source of an exquisite variety of antimicrobials that can lead to useful therapeutics in the future. In this review, natural preparations used since antiquity for treating tuberculosis are described, together with a rapid view of the 20th century antibiotic development against TB. Finally a summary of the most potent recent natural antimycobacterials is displayed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201841     DOI: 10.2741/4024

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  13 in total

Review 1.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

2.  DNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities.

Authors:  Federico Brucoli; Juan D Guzman; Mohammad A Basher; Dimitrios Evangelopoulos; Eleanor McMahon; Tulika Munshi; Timothy D McHugh; Keith R Fox; Sanjib Bhakta
Journal:  J Antibiot (Tokyo)       Date:  2016-05-11       Impact factor: 2.649

3.  Synthesis and antibacterial evaluation of a new series of N-Alkyl-2-alkynyl/(E)-alkenyl-4-(1H)-quinolones.

Authors:  Abraham Wube; Juan-David Guzman; Antje Hüfner; Christina Hochfellner; Martina Blunder; Rudolf Bauer; Simon Gibbons; Sanjib Bhakta; Franz Bucar
Journal:  Molecules       Date:  2012-07-09       Impact factor: 4.411

4.  Anti-inflammatory and antioxidative effects of six pentacyclic triterpenes isolated from the Mexican copal resin of Bursera copallifera.

Authors:  Antonio Romero-Estrada; Amalia Maldonado-Magaña; Judith González-Christen; Silvia Marquina Bahena; María Luisa Garduño-Ramírez; Verónica Rodríguez-López; Laura Alvarez
Journal:  BMC Complement Altern Med       Date:  2016-10-26       Impact factor: 3.659

5.  Investigation of the anti-TB potential of selected propolis constituents using a molecular docking approach.

Authors:  Mohammad Tuhin Ali; Natalia Blicharska; Jamil A Shilpi; Veronique Seidel
Journal:  Sci Rep       Date:  2018-08-16       Impact factor: 4.379

6.  Screening of Compounds for Anti-tuberculosis Activity, and in vitro and in vivo Evaluation of Potential Candidates.

Authors:  Wei Zhou; Bing Yang; Yanyan Zou; Khaista Rahman; Xiaojian Cao; Yingying Lei; Ren Lai; Zhen F Fu; Xi Chen; Gang Cao
Journal:  Front Microbiol       Date:  2021-06-30       Impact factor: 5.640

7.  Antibacterial Activity of Thymus Syriacus Boiss Essential Oil and Its Components against Some Syrian Gram-Negative Bacteria Isolates.

Authors:  Ayman Al-Mariri; Ghayath Swied; Adnan Oda; Laila Al Hallab
Journal:  Iran J Med Sci       Date:  2013-06

8.  TB Summit 2014: prevention, diagnosis, and treatment of tuberculosis-a meeting report of a Euroscicon conference.

Authors:  Arundhati Maitra; Sanjib Bhakta
Journal:  Virulence       Date:  2014-07-08       Impact factor: 5.882

9.  Tackling tuberculosis: Insights from an international TB Summit in London.

Authors:  Arundhati Maitra; Cynthia A Danquah; Francesca Scotti; Tracey K Howard; Tengku K Kamil; Sanjib Bhakta
Journal:  Virulence       Date:  2015-07-07       Impact factor: 5.882

10.  Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora.

Authors:  Jamil A Shilpi; Mohammad Tuhin Ali; Sanjib Saha; Shihab Hasan; Alexander I Gray; Véronique Seidel
Journal:  In Silico Pharmacol       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.